Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.810
0.00 (0.00%)
Jan 29, 2026, 12:20 PM EST - Market open
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $170.21 million as of January 29, 2026. Its market cap has increased by 78.18% in one year.
Market Cap
170.21M
Enterprise Value
65.00M
1-Year Change
78.18%
Ranking
Category
Stock Price
$2.81
Market Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $170.21M, a decrease of -72.48%. That is a compound annual growth rate of -24.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 170.21M | 33.18% |
| Dec 31, 2025 | 127.81M | 23.68% |
| Dec 31, 2024 | 103.34M | -53.53% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
| Jul 1, 2021 | 618.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sutro Biopharma | 133.24M |
| Sangamo Therapeutics | 129.45M |
| Tharimmune | 127.68M |
| Alpha Cognition | 127.19M |
| Whitehawk Therapeutics | 126.30M |
| Genelux | 126.21M |
| Actuate Therapeutics | 125.17M |
| Cognition Therapeutics | 121.82M |